Atai Life Sciences N.V.

NASDAQ:ATAI

1.35 (USD) • At close November 7, 2024
Overzicht | Financiële gegevens

Cijfers zijn in miljoenen (behalve de cijfers per aandeel en de ratio's) USD.

2024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q1
Omzet 0.27300.0180.0870.1720.0370.0380.0240.1700.230.266019.880000
Kosten van de omzet 0.0820.0830.1010.0740.1950.1670.0530.0360.0190.060.02900.0190002.8130
Brutowinst 0.191-0.083-0.0830.013-0.023-0.13-0.015-0.0120.151-0.060.2010.266-0.01919.8800-2.8130
Brutowinstmarge 0.70-4.6110.149-0.134-3.514-0.395-0.50.88800.8741010000
Onderzoek- en ontwikkelingskosten 12.52311.44714.05513.2915.47619.28121.87619.02817.94915.4619.52813.36316.0265.5853.3523.0582.8542.144
Algemene en administratieve kosten 13.39712.55519.42313.63116.55813.9715.72719.41917.22117.98225.87720.26437.3319.27371.9854.3282.8511.57
Verkoop- en marketingkosten 0.152-00000000000000000
Verkoop-, algemene en administratieve kosten 13.39712.45519.42313.63116.55813.9715.72719.41917.22117.98225.87720.26437.3319.27371.9854.3282.8511.57
Overige kosten -0.667-0.005-0.11170.6810.2040.058-1.756-0.1-0.0120-3.28-0.029-3.1891.374-2.724-13.878-1.2971.762
Bedrijfskosten 25.9223.90233.47826.92132.03433.25137.60338.44735.1733.44245.40533.62753.35714.85875.3377.3865.7053.714
Bedrijfsresultaat -25.729-23.985-33.561-26.834-31.862-32.534-37.565-38.423-35.357-33.442-45.175-33.361-61.3194.05-87.237-7.386-5.825-3.714
Bedrijfsresultaat ratio -94.2450-1,864.5-308.437-185.244-879.297-988.553-1,600.958-207.9820-196.413-125.41700.2040000
Totaal overige inkomsten en kosten netto -31.729-1.69615.24170.6810.204-0.622-1.7565.2894.5511.521-3.3246.879-13.9790.694-15.917-13.961-1.45921.594
Inkomen voor belasting -57.458-25.681-18.3243.847-31.658-33.156-39.321-33.134-30.806-31.921-48.579-26.474-67.3015.753-91.24-21.328-7.14617.901
Inkomen voor belasting ratio -210.4690-1,017.778503.989-184.058-896.108-1,034.763-1,380.583-181.2120-211.213-99.52600.2890000
Belastingkosten -0.362-0.0040.4280.2380.1850.1656.0020.1350.0510.041-4.4210.3680.0580.0060.3010.0049.355-18.254
Nettowinst -57.312-26.713-18.29244.244-33.042-33.321-45.323-33.269-30.857-31.962-88.877-31.158-48.4610.688-86.594-83.195-16.35716.302
Nettowinstmarge -209.9340-1,016.222508.552-192.105-900.568-1,192.711-1,386.208-181.5120-386.422-117.13500.0350000
WPA (Winst Per Aandeel) -0.36-0.17-0.120.28-0.21-0.21-0.29-0.22-0.2-0.21-0.59-0.21-0.370.005-0.57-0.55-0.110.11
Verwaterde WPA -0.36-0.17-0.120.28-0.21-0.21-0.29-0.21-0.2-0.21-0.59-0.21-0.370.005-0.57-0.55-0.110.11
EBITDA -25.647-23.902-33.46-26.834-31.862-33.214-37.565-43.631-39.07-34.805-45.175-40.269-42.5485.708-62.13-7.298-5.54-23.544
EBITDA ratio -93.9450-1,858.889-308.437-185.244-897.676-988.553-1,817.958-229.8240-196.413-151.38700.2870000